s 9977 has been researched along with 1-methyl-3-isobutylxanthine in 1 studies
Studies (s 9977) | Trials (s 9977) | Recent Studies (post-2010) (s 9977) | Studies (1-methyl-3-isobutylxanthine) | Trials (1-methyl-3-isobutylxanthine) | Recent Studies (post-2010) (1-methyl-3-isobutylxanthine) |
---|---|---|---|---|---|
5 | 0 | 0 | 5,148 | 5 | 279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baux, G; Fossier, P; Tauc, L; Trudeau, LE | 1 |
1 other study(ies) available for s 9977 and 1-methyl-3-isobutylxanthine
Article | Year |
---|---|
Xanthine derivatives IBMX and S-9977-2 potentiate transmission at an Aplysia central cholinergic synapse.
Topics: 1-Methyl-3-isobutylxanthine; Acetylcholine; Acetylcholinesterase; Animals; Aplysia; Brain; Carbachol; Electrophysiology; Parasympathetic Nervous System; Piperazines; Synapses; Synaptic Transmission; Xanthines | 1992 |